Using a Composite Outcome in Estimating the Effect of Co-trimoxazole Prophylaxis on Prognosis in African Adults Receiving Antiretroviral Therapy

Affiliations

¹ School of Physical Therapy. Universidad Industrial de Santander, Bucaramanga, Colombia.
² Department of Epidemiology, Laboratório de Inferência Causal em Epidemiologia, University of São Paulo, São Paulo, Brazil.

Comment

Paula C Ramírez et al. Clin Infect Dis. 2021.

. 2021 Oct 20;73(8):1550-1551.

doi: 10.1093/cid/ciab362.

¹ School of Physical Therapy. Universidad Industrial de Santander, Bucaramanga, Colombia.
² Department of Epidemiology, Laboratório de Inferência Causal em Epidemiologia, University of São Paulo, São Paulo, Brazil.

No abstract available

Comment in

Reply to Ramirez and Diaz-Quijano.
Laurens MB, Downs M, Laufer MK. Laurens MB, et al. Clin Infect Dis. 2021 Oct 20;73(8):1551-1552. doi: 10.1093/cid/ciab364. Clin Infect Dis. 2021. PMID: 33900389 Free PMC article. No abstract available.

Revisiting Co-trimoxazole Prophylaxis for African Adults in the Era of Antiretroviral Therapy: A Randomized Controlled Clinical Trial.
Laurens MB, Mungwira RG, Nampota N, Nyirenda OM, Divala TH, Kanjala M, Mkandawire FA, Galileya LT, Nyangulu W, Mwinjiwa E, Downs M, Tillman A, Taylor TE, Mallewa J, Plowe CV, van Oosterhout JJ, Laufer MK. Laurens MB, et al. Clin Infect Dis. 2021 Sep 15;73(6):1058-1065. doi: 10.1093/cid/ciab252. Clin Infect Dis. 2021. PMID: 33744963 Free PMC article. Clinical Trial.